EVAX Evaxion A/S

NASDAQ
$3.07

Evaxion A/S (EVAX) is confirmed to report earnings on November 19, 2026, before the market open. The stock has had a Post-Earnings Announcement Drift (PEAD) of -9.7% since its last earnings release on August 20, 2026.

Evaxion A/S Reported Earnings
Thursday, August 20, 2026 · 7:30 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 19
Thursday · 7:30 AM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $3.25

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Evaxion A/S

Evaxion is a pioneering TechBio company based upon its proprietary, clinically validated and scalable AI platform, AI-Immunology™.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.